5mgPurity Exceeds 99%
Retatrutide 5mg
Retatrutide (LY3437943)
Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors. Its triagonist profile allows investigation of energy regulation, fat mobilization, and glycemic control within a single compound.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications.
Purity
Purity Exceeds 99%
Storage
36-46°F (2-8°C)
Origin
Made in USA
Documentation
COA Available
Procurement Information
This product is available exclusively to qualified research institutions and licensed facilities through authorized distribution channels.
- Valid research credentials required
- Orders processed through authorized agents only
- End-user certification documentation required
Research Mechanisms
- Triple receptor agonist (GLP-1, GIP, and Glucagon)
- Energy expenditure modulation via glucagon receptor activation
- Lipid metabolism and fat mobilization research
- Glucose-dependent insulin secretion
- Central appetite suppression
Research Background
- Phase 2 clinical data published in NEJM (2023)
- TRIUMPH Phase 3 program ongoing
- Studies showing up to 24% body weight reduction in models
- Research into NASH and hepatic steatosis
Storage & Handling
Recommended Storage Conditions
Store at 36–46°F (2–8°C). Protect from light. Do not freeze.
- - Keep away from direct sunlight
- - Maintain consistent temperature
- - Check expiration date before use
- - Reconstituted peptides: use within 28 days